NYAMU v. MERCK & CO.

CourtDistrict Court, E.D. Pennsylvania
DecidedSeptember 8, 2025
Docket2:22-cv-04788
StatusUnknown

This text of NYAMU v. MERCK & CO. (NYAMU v. MERCK & CO.) is published on Counsel Stack Legal Research, covering District Court, E.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
NYAMU v. MERCK & CO., (E.D. Pa. 2025).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA PETER NYAMU, CIVIL ACTION Plaintiff, v. MERCK & CO., NO. 22-4788 Defendant. HODGE, J. September 8, 2025 MEMORANDUM Plaintiff Peter Nyamu (“Nyamu” or “Plaintiff”) claims that his employer Merck Sharp & Dohme LLC (“Merck” or “Defendant”) created a hostile work environment of sexual harassment due to his sex (Count II) and retaliated against him for reporting this harassment (Count I). Plaintiff brings these claims under Title VII of the Civil Rights Act of 1964 (“Title VII”). Before the Court are Plaintiff and Defendant’s respective cross-motions for summary judgment. (ECF Nos. 28, 31.) For the reasons that follow, Defendant’s motion is granted and Plaintiff’s motion is denied.

I. BACKGROUND From September 2010 until the fall of 2021, Plaintiff worked for Merck as a biotechnician in Department 245, where he was primarily responsible for growing, harvesting, and storing live virus cells to manufacture vaccines. (ECF No. 32-2 at 31-32, 35, 83.) In that role, Plaintiff was represented by the United Steelworkers Union Local 10-00086 (“the Union”). The terms and conditions of Plaintiff’s employment were governed by a collective bargaining agreement (“CBA”) negotiated between Merck and the Union. (ECF No. 32-4.) A biotechnician’s role includes “[h]andl[ing] live organisms and chemical substances” using “[s]terile technique.” (ECF No. 32-10 at 5.) To ensure compliance with its directives, Merck maintains Standard Operating Procedures (“SOP”), including SOP-16283, which includes monitoring to ensure the maintenance of sterile environments and responding to tests that reveal unacceptable contamination. (ECF No. 32-11.) SOP-16283 requires biotechnicians whose work requires them to enter sterile gowning areas to undergo routine testing using Replicate Organism

Detection And Counting (“RODAC”) plates. These tests identify any contamination after an employee dons a gown and before they enter a sterile environment. (ECF No. 32-5 at 66-67; ECF No. 32-2 at 54-55.) An “excursion” occurs when a RODAC test reveals contamination by micro- organisms on a biotechnician’s sterile gown or gloved hands. (ECF No. 32-11 at 27; ECF No. 32- 5 at 64). As relevant here, SOP-16283 requires that, if a biotechnician fails RODAC testing six times within a year, they be disqualified from working in the sterile area for a year and then retrained. (ECF No. 32-11 at 27, 34.) In August 2021, after having accumulated six excursions in a year, Plaintiff was excluded from working in the sterile area for one year pursuant to SOP-16283. (ECF No. 32-2 at 44-45; ECF No. 32-5 at 74-75.) Once he was excluded from the sterile core, Plaintiff was only able to

perform around 30% of his tasks as a biotechnician. (ECF No. 32-14 at 3.) Given Plaintiff’s inability to perform most of the work in Department 245, Defendant decided to give him the opportunity—pursuant to the CBA—to “bid” on, or apply to, open positions in the bargaining unit for which he was qualified. (ECF No. 32-2 at 117-119.) The CBA also contains a “flex flow” procedure, which gives Merck the ability to temporarily move an employee to another department based on business needs, subject to requirements in the CBA. (Id. at 119.) If Plaintiff did not successfully bid into a new role by the end of 2021, he would be flex flowed to a department that did not require sterile gowning until his disqualification was over. (ECF No. 32-5 at 59-61, 82- 83.) On September 14, 2021, Plaintiff filed a grievance regarding his supervisor, Paul Jackson (“Jackson”), stating that “Jackson is creating a hostile work environment for me by targeting me where by [sic] he reserves condescending remarks for me but none for my workmates that I pair with for work.” (ECF No. 32-7 at 2.) During his deposition, Plaintiff testified that there were five

incidents that formed the basis for his September 14 grievance. As relevant here, Plaintiff alleged that, at a staff meeting on July 25, 2021, Jackson was handing out schedules to employees and forgot to give one to Plaintiff, which Plaintiff alerted Jackson to. (ECF No. 32-2 at 68.) According to Plaintiff, Jackson responded by “[coming] close to me, next to my ear, and he whispered, ‘I don’t know how I missed to give you a schedule because I use your voice to know where you are standing . . . You have a voice that is very specific to me.” (Id.) On November 13, 2021, Plaintiff filed a grievance asserting that overtime was not being distributed in accordance with the CBA. (ECF No. 32-17.) Four days later, Plaintiff met with his union shop steward, along with Jackson and another supervisor, and discussed Merck’s decision to permit Plaintiff to bid into another position or be temporarily flex flowed until the end of his

disqualification from the sterile area. (ECF No. 32-16.) Following this meeting, Plaintiff declined to bid on any positions. (ECF No. 32-3 at 17.) On November 19, 2021, Plaintiff filed a grievance arguing that his alleged decrease in overtime shifts and impending flex flow was in retaliation for his September grievance regarding Jackson. (ECF No. 32-18 at 2.) The following day, on November 20, Plaintiff filed another grievance complaining about the same issues, but this time, he alleged that Defendant’s actions were based on Plaintiff being “of African descent.” (ECF No. 32-19 at 2.) On March 27, 2022, Plaintiff was flex flowed to Department 241, where the majority of work does not need to be performed in a sterile environment. (ECF No. 32-3 at 55.) On June 5, 2022, Plaintiff filed a charge with the U.S. Equal Employment Opportunity Commission (“EEOC”) (ECF No. 32-38), and on September 30, 2022, the EEOC issued a Dismissal and Notice of Rights (ECF No. 32-39). Meanwhile, Plaintiff returned to Department 245 in August 2022 when he was eligible to requalify to work in the sterile area. (ECF No. 32-3

at 135.) Plaintiff remained in Department 245 until January 2023 when he bid into a role in another department, where he remains today. (ECF No. 32-13 at 140.) As a result of the alleged “harassing behavior and hostile work environment” that Defendant “subjected” him to, Plaintiff claims he has developed anxiety disorder. (ECF No. 10 at ⁋ 74.) He also alleges that he has suffered “both economic and non-economic damages as a direct and proximate result of Merck’s and Mr. Jackson’s retaliation against him.” (Id. at ⁋ 90.) After discovery was completed, Plaintiff moved for summary judgment on Count I (retaliation) of his Amended Complaint (ECF No. 28), which has been fully briefed (ECF No. 33). Subsequent to Plaintiff’s filing, Defendant moved for summary judgment on Count I as well as Count II (hostile work environment) (ECF No. 31), which has also been fully briefed (ECF Nos.

35, 36). II. LEGAL STANDARD The standard for assessing motions for summary judgment is well-settled. Summary judgment is appropriate “if the movant shows that there is no genuine dispute as to any material fact and the movant is entitled to judgment as a matter of law.” Fed. R. Civ. P. 56(a). The Court must ask whether the evidence presents “a sufficient disagreement to require submission to a jury or whether it is so one-sided that one party must prevail as a matter of law.” Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 251-52 (1986). In making this determination, “‘[a]ll reasonable inferences from the record must be drawn in favor of the nonmoving party’ and the court ‘may not weigh the evidence or assess credibility.’” Goldenstein v. Repossessors Inc., 815 F.3d 142, 146 (3d Cir. 2016) (quoting MBIA Ins. Corp. v. Royal Indem.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

McDonnell Douglas Corp. v. Green
411 U.S. 792 (Supreme Court, 1973)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Harris v. Forklift Systems, Inc.
510 U.S. 17 (Supreme Court, 1993)
Faragher v. City of Boca Raton
524 U.S. 775 (Supreme Court, 1998)
John K. Rains v. Cascade Industries, Inc
402 F.2d 241 (Third Circuit, 1968)
Mandel v. M & Q Packaging Corp.
706 F.3d 157 (Third Circuit, 2013)
Marra v. Philadelphia Housing Authority
497 F.3d 286 (Third Circuit, 2007)
Lawrence v. City of Philadelphia, Pa.
527 F.3d 299 (Third Circuit, 2008)
Clark County School District v. Breeden
532 U.S. 268 (Supreme Court, 2001)
Dorothy Daniels v. Philadelphia School District
776 F.3d 181 (Third Circuit, 2015)
Moore v. City of Philadelphia
461 F.3d 331 (Third Circuit, 2006)
Doreen Burgess v. Dollar Tree Stores
642 F. App'x 152 (Third Circuit, 2016)
Heiko Goldenstein v. Repossessors Inc.
815 F.3d 142 (Third Circuit, 2016)
Jeffrey Kengerski v. Orlando Harper
6 F.4th 531 (Third Circuit, 2021)
Diodato v. Wells Fargo Insurance Services, USA, Inc.
44 F. Supp. 3d 541 (M.D. Pennsylvania, 2014)
LaRochelle v. Wilmac Corp.
210 F. Supp. 3d 658 (E.D. Pennsylvania, 2016)

Cite This Page — Counsel Stack

Bluebook (online)
NYAMU v. MERCK & CO., Counsel Stack Legal Research, https://law.counselstack.com/opinion/nyamu-v-merck-co-paed-2025.